China’s Clover Biopharmaceuticals starts COVID-19 clinical trials in PH — DOST / by Charissa Luci-Atienza

By:

Subject(s):

Online resources:

Hello from Record Display Customizations!

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Cover image	Item type	Current library	Home library	Collection	Shelving location	Call number	Materials specified	Vol info	URL	Copy number	Status	Notes	Date due	Barcode	Item holds	Item hold queue priority	Course reserves
	News Clippings	DOH Central Library Electronic Resource Section				033021-010 (Browse shelf(Opens below))					Available			D0001NC033021-010

Browsing DOH Central Library shelves,Shelving location: Electronic Resource Section Close shelf browser (Hides shelf browser)

Previous	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	Next
Previous	033021-007 Manila seniors get their jabs /	033021-008 Ivermectin eligible for ‘compassionate use’ /	033021-009 WHO slammed for justifying plan to stop tobacco firms from buying vaccines	033021-010 China’s Clover Biopharmaceuticals starts COVID-19 clinical trials in PH — DOST /	033021-011 OCTA: 1-week ECQ not enough to bring down hospital utilization in NCR+ /	033021-012 COVID-19 variant first found in PH also detected in Germany, UK, Japan, Australia /	040621-001 An urgent plea to PRRD and Congress on Ivermectin to fight COVID /	Next

There are no comments on this title.

to post a comment.

Back to results